[1]
von Stebut, E., Reich, K., Thaci, D., Koenig, W., Pinter, A., Korber, A., Rassaf, T., Waisman, A., Mani, V., Yates, D., Frueh, J., Sieder, C., Melzer, N. and Gori, T. 2018. Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S20. DOI:https://doi.org/10.25251/skin.2.supp.20.